Cited by 253Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology ResearchDementia and Cognitive Impairment Research

Synaptic Changes in Alzheimer's Disease

Open access
Gylys, Karen Hoppens, Fein, Jeffrey A., Yang, Fusheng, Wiley, Dorothy J., Miller, Carol A., Cole, Gregory M.·2004·The American Journal of Pathology

Abstract

In an effort to examine changes that precede synapse loss, we have measured amyloid-beta and a series of damage markers in the synaptic compartment of Alzheimer's disease (AD) cases. Because localization of events to the terminal region in neurons is problematic with conventional methods, we prepared synaptosomes from samples of cryopreserved human association cortex, and immunolabeled terminals with a procedure for intracellular antigens. Fluorescence was quantified using flow cytometry. The viability dye calcein AM was unchanged in AD terminals compared to controls, and the fraction of large synaptosome particles did not change, although a striking loss of large terminals was observed in some AD cases. The percent positive fraction for a series of pre- and postsynaptic markers was not affected by AD in this cohort. However, the amyloid-beta-positive fraction increased from 16 to 27% (P < 0.02) in terminals from AD cortex. The expression level on a per-terminal basis is indicated in this assay by fluorescence (relative fluorescence units). The fluorescence of presynaptic markers did not change in AD terminals, but PSD-95 fluorescence was decreased by 19% (P < 0.03). Amyloid-beta fluorescence was increased by 132% (P < 0.01), and glial fibrillary acidic protein labeling by 31% (P < 0.01). These results suggest that synapse-associated amyloid-beta is prominent in regions relatively unaffected by AD lesions, and that amyloid accumulation in surviving terminals is accompanied by gliosis and alteration in the postsynaptic structure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)63436-0

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • APP mutant neurons show differential alterations in synaptic proteins resembling those in AD brain, including early loss of synaptophysin and PSD-95.

    “Remarkably, APP mutant neurons showed differential alterations in synaptic proteins [3] that resembled those that have been described in AD brain, such as early loss of the pre-synaptic protein synaptophysin [113, 163, 192] and the post-synaptic protein PSD-95 [63].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Gylys KH, Fein JA, Cole GM: Quantitative characterization of crude synaptosomal fraction (P-2) components by flow cytometry. J Neuro- sci Res 2000, 61:186 -192
  2. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB: Amyloid beta-protein fibril- logenesis. Structure and biological activity of protofibrillar intermedi- ates. J Biol Chem 1999, 274:25945-25952

Cited by

Sorted by citations

Authors
Gylys, K. H., Fein, J. A., Yang, F., Wiley, D. J., Miller, C. A., & Cole, G. M.
Affiliations
  • University of California, Los Angeles (US)
  • University of Southern California (US)
Corresponding author
Gylys, Karen Hoppens
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2004-11
Volume
165
Issue
5
Pages
1809-1817
ISSN
0002-9440 (ISSN-L)
OpenAlex
W2135224381
Cited by
253
References
59
Citations by year
2026: 9 · 2025: 10 · 2024: 13 · 2023: 9 · 2022: 9 · 2021: 10 · 2020: 13 · 2019: 9 · 2018: 11 · 2017: 14 · 2016: 11 · 2015: 13 · 2014: 21 · 2013: 13 · 2012: 11
FWCI
4.33
Type
journal article
Language
en
Open access
Locations
  • American Journal Of Pathology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (AI28697, CA16042)
  • National Institute on Aging (AG18879, R01AG018879, P50AG016570, R01AG013741, AG 16570, P50-AG05142, P50AG005142, AG13741)
  • National Cancer Institute (CA-16 042, P30CA016042)
  • National Institute of Allergy and Infectious Diseases (AI-28 697, P30AI028697)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, synaptic loss, amyloid-beta, synaptosomes, synapses, PSD-95, postsynaptic structures, presynaptic terminals, glial fibrillary acidic protein, gliosis, association cortex
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Brain, Female, Flow Cytometry, Glial Fibrillary Acidic Protein, Gliosis, Humans, Male, Membrane Proteins, Models, Biological, Nerve Tissue Proteins, Neurons, Synapses, Time Factors, Blotting, Western, Amyloid beta-Peptides, Synaptosomal-Associated Protein 25

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review